Fox Chase Cancer Center: Choice of First-Line Platinum Regimen Does Not Significantly Impact Efficacy of Second-Line Immunotherapy in Advanced Bladder Cancer

Press/Media

PeriodJun 4 2021

Media coverage

1

Media coverage

  • TitleFox Chase Cancer Center: Choice of First-Line Platinum Regimen Does Not Significantly Impact Efficacy of Second-Line Immunotherapy in Advanced Bladder Cancer
    Media name/outletTargeted News Service
    Country/TerritoryUnited States
    Date06/4/21
    PersonsDaniel Geynisman
View all 1
View less